NAV
$82.67
AUM
$94.4B
Expense Ratio
-
Dividend Yield
1.46%
Beta
0.91
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +14.62% | +3.93% | +10.97% | +26.31% | +18.51% | +8.81% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | 2330.TW | Taiwan Semiconductor Manufacturing Co Ltd | 4.37% |
| 2 | 005930.KS | Samsung Electronics Co Ltd | 2.41% |
| 3 | 000660.KS | SK Hynix Inc | 2.05% |
| 4 | ASML.AS | ASML Holding NV | 1.53% |
| 5 | 0700.HK | Tencent Holdings Ltd | 0.82% |
| 6 | HSBA.L | HSBC Holdings PLC | 0.78% |
| 7 | ROP.SW | Roche Holding AG Ordinary Shares new | 0.72% |
| 8 | NOVN.SW | Novartis AG Registered Shares | 0.70% |
| 9 | AZN.L | AstraZeneca PLC | 0.68% |
| 10 | 9988.HK | Alibaba Group Holding Ltd Ordinary Shares | 0.67% |
The fund employs an indexing investment approach designed to track the performance of the FTSE All-World ex US Index. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Inception Date: 2007-03-02